Women’s Health Therapeutics Market to reach USD 61.6 billion by 2032 and grow at a CAGR of 4.05%.
Growing awareness of women\'s health issues, increasing adoption of modern medical technology, and an aging population are critical factors driving the growth of the women\'s health therapeutics market. The prevalence of conditions such as menopause, PCOS, and breast cancer are also rising considerably and are set to increase demand for specialized treatments. The WHO states that around 10% of women around the world are diagnosed with PCOS. Breast cancer is the most common cancer diagnosed in women, affecting 2.3 million females annually. These numbers speak to the enormous potential for targeted therapeutics to combat such widespread health issues.